Even as inflation plummeted to an archive low.

AARP Report finds upsurge in brand-name medication costs outstrips inflation AARP Bulletin: ‘Retail charges for some of the most widely used brand-name prescription drugs shot up more than 8 % in 2009 2009, even as inflation plummeted to an archive low, today according to a new AARP evaluation of retail drug cost trends released. The AARP Rx Cost Watch Report also looked at retail drug prices in the last five years and discovered some huge increases for popular drugs including the prostate drug Flomax, which doubled in cost nearly; Advair and Aricept noticed price hikes of 40 % Read more about this drug . Through the same period, the consumer price index rose 13.3 %. The Hill’s Healthwatch Blog: ‘Big pharma is pushing back against’ the survey.

AARP launches marketing campaign to preserve health insurance and retirement protection of older Americans With the national debate heating up on raising the debt ceiling, AARP announced a new campaign today to fight against proposals with arbitrary limits, caps or triggers that would bring about harmful cuts to critical Social Security and Medicare benefits that an incredible number of Americans have earned through an eternity of effort. The campaign, with a multi-million dollar national advertising schedule, grassroots and online actions, will engage AARP users and the general public around the potential impact that such proposals could have on current and long term generations, and cause them to become contact their members of Congress to oppose harmful cuts to Sociable Medicare and Security.